ArticleFrontiers in oncology2022

Efficacy and safety of transarterial chemoembolization plus sorafenib in patients with recurrent hepatocellular carcinoma after liver transplantation.

Xia Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.